Femara (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Femara drug offered from Novartis Pharmaceuticals Corporation. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | letrozole |
SUBSTANCE NAME: | LETROZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-07-31 |
END MARKETING DATE: | 0000-00-00 |
Femara HUMAN PRESCRIPTION DRUG Details:
Item Description | Femara from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 1997-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0249_99d0c858-b812-443b-bb8a-5aacf551ce6b |
PRODUCT NDC: | 0078-0249 |
APPLICATION NUMBER: | NDA020726 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers: